Literature DB >> 19890259

Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.

Ju Wang1, Ming D Li.   

Abstract

Twin and family studies reveal a significant genetic contribution to the risk of smoking initiation and progression (SI/P), nicotine dependence (ND), and smoking cessation (SC). Further, numerous genes have been implicated in these smoking-related behaviors, especially for ND. However, no study has presented a comprehensive and systematic view of the genetic factors associated with these important smoking-related phenotypes. By reviewing the literature on these behaviors, we identified 16, 99, and 75 genes that have been associated with SI/P, ND, and SC, respectively. We then determined whether these genes were enriched in pathways important in the neuronal and brain functions underlying addiction. We identified 9, 21, and 13 pathways enriched in the genes associated with SI/P, ND, and SC, respectively. Among these pathways, four were common to all of the three phenotypes, that is, calcium signaling, cAMP-mediated signaling, dopamine receptor signaling, and G-protein-coupled receptor signaling. Further, we found that serotonin receptor signaling and tryptophan metabolism pathways were shared by SI/P and ND, tight junction signaling pathway was shared by SI/P and SC, and gap junction, neurotrophin/TRK signaling, synaptic long-term potentiation, and tyrosine metabolism were shared between ND and SC. Together, these findings show significant genetic overlap among these three related phenotypes. Although identification of susceptibility genes for smoking-related behaviors is still in an early stage, the approach used in this study has the potential to overcome the hurdles caused by factors such as genetic heterogeneity and small sample size, and thus should yield greater insights into the genetic mechanisms underlying these complex phenotypes.

Entities:  

Mesh:

Year:  2009        PMID: 19890259      PMCID: PMC2814000          DOI: 10.1038/npp.2009.178

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  171 in total

1.  Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine.

Authors:  Marissa A Ehringer; Hilary V Clegg; Allan C Collins; Robin P Corley; Thomas Crowley; John K Hewitt; Christian J Hopfer; Kenneth Krauter; Jeffrey Lessem; Soo Hyun Rhee; Isabel Schlaepfer; Andrew Smolen; Michael C Stallings; Susan E Young; Joanna S Zeiger
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-07-05       Impact factor: 3.568

2.  Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking.

Authors:  Undine E Lang; Thomas Sander; Falk W Lohoff; Rainer Hellweg; Malek Bajbouj; Georg Winterer; Jürgen Gallinat
Journal:  Psychopharmacology (Berl)       Date:  2006-12-21       Impact factor: 4.530

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Cholecystokinin (CCK) gene as a possible risk factor for smoking: a replication in two independent samples.

Authors:  D E Comings; S Wu; N Gonzalez; W G Iacono; M McGue; W W Peters; J P MacMurray
Journal:  Mol Genet Metab       Date:  2001-08       Impact factor: 4.797

Review 5.  The genetic epidemiology of smoking.

Authors:  P F Sullivan; K S Kendler
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

6.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

7.  Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence.

Authors:  Joke Beuten; Jennie Z Ma; Thomas J Payne; Randolph T Dupont; Karen M Crews; Grant Somes; Nancy J Williams; Robert C Elston; Ming D Li
Journal:  Am J Hum Genet       Date:  2005-03-09       Impact factor: 11.025

8.  Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Authors:  Elaine C Johnstone; Patricia L Yudkin; Kate Hey; Sarah J Roberts; Sarah J Welch; Michael F Murphy; Siân E Griffiths; Robert T Walton
Journal:  Pharmacogenetics       Date:  2004-02

9.  Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample.

Authors:  Weihua Huang; Thomas J Payne; Jennie Z Ma; Joke Beuten; Randolph T Dupont; Naohiro Inohara; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2008-03-19       Impact factor: 7.853

10.  Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment.

Authors:  Colin O'Gara; John Stapleton; Gay Sutherland; Camila Guindalini; Ben Neale; Gerome Breen; David Ball
Journal:  Pharmacogenet Genomics       Date:  2007-01       Impact factor: 2.089

View more
  47 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 2.  Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Authors:  Sean P David; Elaine C Johnstone; Michael Churchman; Paul Aveyard; Michael F G Murphy; Marcus R Munafò
Journal:  Nicotine Tob Res       Date:  2011-01-25       Impact factor: 4.244

3.  From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.

Authors:  Naji C Salloum; Erica L F Buchalter; Swati Chanani; Gemma Espejo; Mahjabeen S Ismail; Randy O Laine; Maysaa Nageeb; A Benjamin Srivastava; Nicholas Trapp; Ludwig Trillo; Erica Vance; Michael Wenzinger; Sarah M Hartz; Sean P David; Li-Shiun Chen
Journal:  Pharmacogenomics       Date:  2018-06-19       Impact factor: 2.533

4.  Associations of CYP2A6 genotype with smoking behaviors in southern China.

Authors:  Tao Liu; Sean P David; Rachel F Tyndale; Hui Wang; Qian Zhou; Peng Ding; Yan-Hui He; Xue-Qing Yu; Wei Chen; Casey Crump; Xiao-Zhong Wen; Wei-Qing Chen
Journal:  Addiction       Date:  2011-05       Impact factor: 6.526

5.  Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits.

Authors:  Ulla Broms; Juho Wedenoja; Marine R Largeau; Tellervo Korhonen; Janne Pitkäniemi; Kaisu Keskitalo-Vuokko; Anja Häppölä; Katri H Heikkilä; Kauko Heikkilä; Samuli Ripatti; Antti-Pekka Sarin; Outi Salminen; Tiina Paunio; Michele L Pergadia; Pamela A F Madden; Jaakko Kaprio; Anu Loukola
Journal:  Nicotine Tob Res       Date:  2012-01-12       Impact factor: 4.244

6.  Genetics and smoking.

Authors:  Anu Loukola; Jenni Hällfors; Tellervo Korhonen; Jaakko Kaprio
Journal:  Curr Addict Rep       Date:  2014-03-01

7.  Significant association of glutamate receptor, ionotropic N-methyl-D-aspartate 3A (GRIN3A), with nicotine dependence in European- and African-American smokers.

Authors:  Jennie Z Ma; Thomas J Payne; Justin Nussbaum; Ming D Li
Journal:  Hum Genet       Date:  2010-01-19       Impact factor: 4.132

8.  Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study.

Authors:  Ulla Broms; Marjaana Pennanen; Kristiina Patja; Hanna Ollila; Tellervo Korhonen; Aino Kankaanpää; Ari Haukkala; Annamari Tuulio-Henriksson; Markku Koskenvuo; Erkki Kronholm; Tiina Laatikainen; Markku Peltonen; Timo Partonen; Jaakko Kaprio
Journal:  J Addict Res Ther       Date:  2012-01-25

9.  Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.

Authors:  Yanshi Hu; Zhenhua Pan; Ying Hu; Lei Zhang; Ju Wang
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

Review 10.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.